Fulgent: when the SEC filing says 'DOJ CID' and 'unsealed qui tam', the short isn't optional - it's the base case risk premium
The Opportunity
This is the cleanest risk signal in the batch because it is anchored to issuer disclosure, not to law-firm spam or forum chatter. Upstream direction is SHORT: FCA and kickback-style allegations are exactly the category where downside can be nonlinear, because the market starts pricing not just penalties but reimbursement friction, payer distrust, and governance overhead. The edge remains intact because this is still being treated as contained in upstream lifecycle, and because the information is procedural and filing-based rather than a fully mainstream narrative wave.
The Timing
Freshness is 85 with no staleness flag, and the trade confidence is 28, which reads as 'real risk, messy path'. In Mixed 68 conditions, the trade becomes about headline cadence: unsealing, government intervention decisions, and any subsequent disclosure tightening. What would contradict the short thesis is rapid de-escalation language in subsequent filings or a clear statement that narrows scope materially; what would confirm is any indication of escalation (intervention, expanded CIDs, or payer actions).
The Evidence
The upstream primary source is FLGT's SEC filing, which explicitly references a DOJ CID and notes that a qui tam complaint and related proceedings were unsealed around February 2026, with allegations about medically unnecessary testing, billing, and kickback/Stark themes ( sec.gov ). Upstream also flags law-firm 'investigation alert' distribution as amplification risk rather than incremental evidence ( globenewswire.com ).